Reata Puts Hopes On Partner Study To Support Bardoxolone Resubmission

 
• By Joseph Haas
CKD Reata image
CRL is Reata's latest setback in R&D for rare forms of chronic kidney disease • Source: Alamy

More from New Products

More from Scrip